DAX Closes at 2-Week Low

2026-04-28 16:04 By Luisa Carvalho 1 min. read

Frankfurt's DAX 40 finished about 0.3% down at 24,018 on Tuesday, the lowest in two weeks, extending losses for the seventh consecutive session.

Investors remained focused on developments in the Middle East, while also monitoring corporate earnings ahead of central bank decisions.

Meanwhile, concerns about the resilience of the AI sector resurfaced, after the Wall Street Journal reported that OpenAI missed its targets for new users and revenue.

Among key movers, Qiagen NV plunged nearly 11% on weaker Q1 results and reduced full-year 2026 guidance.

Bayer shares slipped 4.5% after a US Supreme Court hearing on its Roundup weedkiller failed to provide a clear signal, leaving investors uncertain about its bid to avoid billions in cancer-related claims.

Other top losers included Siemens Energy, Zalando and Henkel, down 2.4%, 2.2% and 2%, respectively.

On the flip side, Merck and Commerzbank posted the biggest gains, rising around 2.1% each.



News Stream
The DAX Index Closes 0.27% Lower
The DAX Index dropped 65 points or 0.27 percent on Tuesday to close at 24018 points. Losses were led by Qiagen NV (-10.54%), Bayer (-4.59%) and Zalando (-3.07%). Offsetting the fall, top gainers were Merck (2.29%), Commerzbank (2.10%) and RWE (1.22%).
2026-04-28
DAX Closes at 2-Week Low
Frankfurt's DAX 40 finished about 0.3% down at 24,018 on Tuesday, the lowest in two weeks, extending losses for the seventh consecutive session. Investors remained focused on developments in the Middle East, while also monitoring corporate earnings ahead of central bank decisions. Meanwhile, concerns about the resilience of the AI sector resurfaced, after the Wall Street Journal reported that OpenAI missed its targets for new users and revenue. Among key movers, Qiagen NV plunged nearly 11% on weaker Q1 results and reduced full-year 2026 guidance. Bayer shares slipped 4.5% after a US Supreme Court hearing on its Roundup weedkiller failed to provide a clear signal, leaving investors uncertain about its bid to avoid billions in cancer-related claims. Other top losers included Siemens Energy, Zalando and Henkel, down 2.4%, 2.2% and 2%, respectively. On the flip side, Merck and Commerzbank posted the biggest gains, rising around 2.1% each.
2026-04-28
DAX Extends Losses
Frankfurt's DAX 40 fell 0.4% to below 24,000 on Tuesday, the seventh consecutive session of losses, as traders continued to weigh the lack of progress in US–Iran negotiations over reopening the Strait of Hormuz, along with rising oil prices. US President Trump and his national security team are reportedly skeptical of Iran’s proposal to reopen the Strait of Hormuz and postpone discussions on its nuclear activities. Investors also focused on corporate earnings and upcoming major central bank decisions later this week. Qiagen NV was the biggest laggard, down over 6% on weaker Q1 results and reduced full-year 2026 guidance. Bayer fell as much as 6.5% as the US Supreme Court appeared divided in its handling of the glyphosate litigation. Henkel fell 2.2% as the stock traded ex-dividend today. On the upside, RWE gained 1.5% after Barclays reiterated a Buy rating, while Deutsche Börse rose 0.7% after reporting an 11% increase in Q1 net profit and confirming its 2026 guidance.
2026-04-28